Sleep apnea (especially obstructive sleep apnea, OSA) is widespread, but how common it is depends on sex, age, and what diagnostic threshold is used. Risk climbs with factors like obesity and male sex, and untreated OSA is tied to cardiovascular harms including hypertension and stroke. On this page, explore prevalence across the US and worldwide, identify key symptoms such as snoring and sleepiness, and review evidence-based options like CPAP, oral appliances, weight loss, and surgery.
Key Takeaways
- Untreated OSA increases hypertension risk by 50%
- OSA patients have 2.3-fold higher risk of stroke
- Severe OSA triples coronary heart disease risk
- In the United States, an estimated 25 million adults aged 30-70 have obstructive sleep apnea (OSA), representing about 1 in 4 adults in this age group with at least mild OSA
- Globally, the age-standardized prevalence of at least moderate OSA (apnea-hypopnea index ≥15 events/hour) is 17.4% in men and 9.7% in women, equating to approximately 936 million adults aged 30-69 years
- Among US adults, the prevalence of moderate to severe OSA (AHI ≥15) is 13% in men and 6% in women, with higher rates in obese populations exceeding 30%
- Obesity increases OSA risk by 10-fold in men and 6-fold in women
- Male gender confers a 2-3 times higher risk of OSA compared to females pre-menopause
- Age over 40 years increases OSA risk, with odds ratio of 2.5 per decade in men
- Loud snoring occurs in 70-90% of OSA patients nightly
- Excessive daytime sleepiness affects 40-60% of untreated OSA patients, measured by Epworth Sleepiness Scale >10
- Witnessed apneas reported by bed partners in 50% of moderate-severe OSA cases
- CPAP reduces cardiovascular events by 36% in adherent patients
- Oral appliances reduce AHI by 50% in mild-moderate OSA
- Weight loss of 10% body weight decreases AHI by 26%
Untreated severe sleep apnea raises stroke, heart disease, and death risks, while CPAP and weight loss help most.
Related reading
01 · Category
Health Impacts/complications30 stats
01
Untreated OSA increases hypertension risk by 50%
02
OSA patients have 2.3-fold higher risk of stroke
03
Severe OSA triples coronary heart disease risk
04
All-cause mortality 3-fold higher in untreated severe OSA (AHI>30)
05
OSA contributes to 20% of atrial fibrillation cases
06
Type 2 diabetes risk increases 1.6-fold per 10-unit AHI rise
07
Motor vehicle crashes 2-7 times higher in OSA drivers
08
Depression odds ratio 2.7 in moderate-severe OSA
09
Pulmonary hypertension develops in 20-40% severe OSA
10
Cognitive decline accelerates 1.5-fold with untreated OSA
11
Heart failure risk doubles with AHI ≥30 events/hour
12
NAFLD prevalence 60% in OSA patients vs 20% controls
13
Sudden cardiac death peaks during sleeping hours in OSA by 5-fold
14
Erectile dysfunction affects 60-70% men with severe OSA
15
Pediatric OSA causes growth retardation in 20-30% cases
16
Arrhythmia risk increases 4-fold in severe OSA
17
Healthcare costs 2-3 times higher for OSA patients ($13,900/year vs $5,000)
18
ADHD-like symptoms in 25% untreated pediatric OSA
19
Right ventricular dysfunction in 31% moderate-severe OSA
20
Occupational errors increase 30% in undiagnosed OSA workers
21
Dementia risk 1.7-fold higher with chronic hypoxemia from OSA
22
GERD symptoms worsen 2-fold with supine OSA position
23
Metabolic syndrome components increase 2.5-fold with OSA
24
Work absenteeism 1.9 times higher in OSA employees
25
Enuresis nocturnal in 40% pediatric OSA cases
26
LVH prevalence 38% in OSA vs 15% non-OSA hypertensives
27
Anxiety disorders 3-fold higher in OSA populations
28
Airway inflammation markers elevated 2-fold in OSA
29
Pregnancy complications like preeclampsia 2-fold with OSA
30
CKD progression accelerates 1.8-fold with severe OSA
Interpretation
Health Impacts/complications Interpretation
From the Health Impacts and complications perspective, the data show that untreated or severe obstructive sleep apnea is tied to major cardiovascular outcomes, including a 50% higher hypertension risk, 2.3 times higher stroke risk, and up to a threefold increase in coronary heart disease and all-cause mortality.
02 · Category
Prevalence/epidemiology30 stats
01
In the United States, an estimated 25 million adults aged 30-70 have obstructive sleep apnea (OSA), representing about 1 in 4 adults in this age group with at least mild OSA
02
Globally, the age-standardized prevalence of at least moderate OSA (apnea-hypopnea index ≥15 events/hour) is 17.4% in men and 9.7% in women, equating to approximately 936 million adults aged 30-69 years
03
Among US adults, the prevalence of moderate to severe OSA (AHI ≥15) is 13% in men and 6% in women, with higher rates in obese populations exceeding 30%
04
In Europe, the prevalence of OSA in middle-aged adults is around 9-38% for men and 4-17% for women depending on diagnostic criteria used
05
Among African American adults in the US, OSA prevalence is 19% for moderate to severe cases compared to 10% in Caucasians, adjusted for age and BMI
06
In children aged 2-8 years, OSA prevalence is 1-5% in the general population, rising to 13-59% in obese children
07
In Australia, 9% of women and 25% of men have clinically significant OSA (AHI >10 with symptoms)
08
In Asian populations, OSA prevalence is 14.6% for AHI ≥5 and 6.9% for AHI ≥15, lower than Western populations due to craniofacial differences
09
In the UK, undiagnosed OSA affects 4 million adults, with only 0.5 million diagnosed
10
Prevalence of central sleep apnea (CSA) is 0.9% in men and 0.4% in women in general populations, higher in heart failure patients at 25-40%
11
In pregnant women, OSA prevalence increases from 15.8% in first trimester to 26.1% in third trimester
12
Among truck drivers in the US, OSA prevalence is 28.2% for moderate to severe cases
13
In India, OSA prevalence is 13.5% in urban males and 5.3% in urban females
14
In Brazil, 32.8% of adults have OSA, with 20.8% moderate to severe
15
Pediatric OSA prevalence in the US is 1.2-5.7% based on PSG criteria
16
In Saudi Arabia, OSA prevalence is 29.6% in males and 13.9% in females
17
Among US veterans, OSA prevalence is 47-82% depending on subgroup
18
In Japan, OSA prevalence is 3.5% for AHI ≥20 in men aged 40-69
19
Global pediatric OSA affects 20-30% of obese children worldwide
20
In Canada, 17% of men and 7% of women aged 20-79 have moderate to severe OSA
21
Among shift workers, OSA prevalence is 1.5 times higher than day workers
22
In South Korea, OSA prevalence is 27.9% in men and 19.2% in women aged 40-69
23
In elderly US populations (>65 years), OSA prevalence exceeds 50%
24
Among American Indians, OSA prevalence is 29% for moderate to severe
25
In Spain, 26.4% of males and 13.9% of females have OSA (AHI ≥10)
26
Global untreated OSA contributes to 38,000 cardiovascular deaths annually
27
In China, urban OSA prevalence is 20.8% for AHI ≥15
28
Among US Hispanics, OSA prevalence is 14.7% moderate to severe
29
In Germany, 22% of men and 10% of women aged 40-80 have OSA
30
Undiagnosed OSA in US adults is estimated at 80-85% of cases
Interpretation
Prevalence/epidemiology Interpretation
Across countries and age groups, obstructive sleep apnea is highly prevalent, affecting about 25 million adults in the US and globally reaching 17.4% in men versus 9.7% in women, with risk also rising sharply in obesity and in children where prevalence can climb from 1–5% in the general population to 13–59% in obese children.
03 · Category
Risk Factors30 stats
01
Obesity increases OSA risk by 10-fold in men and 6-fold in women
02
Male gender confers a 2-3 times higher risk of OSA compared to females pre-menopause
03
Age over 40 years increases OSA risk, with odds ratio of 2.5 per decade in men
04
Family history of OSA raises risk by 2-fold due to genetic predisposition
05
Smoking increases OSA risk by 2.3 times due to upper airway inflammation
06
Nasal congestion or allergies elevate OSA risk by 2.4 times
07
Menopause increases OSA risk in women by 3-fold due to hormonal changes
08
Acromegaly patients have 81% OSA prevalence due to soft tissue overgrowth
09
Hypothyroidism triples OSA risk through myxedema and weight gain
10
Alcohol consumption within 3 hours of bedtime increases OSA severity by 25%
11
Sedentary lifestyle raises OSA risk by 1.7 times independent of BMI
12
Craniofacial abnormalities like micrognathia increase OSA risk 4-fold
13
PCOS affects 50-70% of women with moderate to severe OSA risk
14
GERD is present in 60% of OSA patients, increasing risk bidirectionally
15
Hypertension precedes OSA diagnosis in 50% of cases, with shared risk
16
Neck circumference >17 inches in men or >16 in women predicts OSA with 65% accuracy
17
Diabetes mellitus type 2 increases OSA risk by 2-3 times
18
Down syndrome children have 50-75% OSA prevalence due to anatomical factors
19
Chronic opioid use raises CSA risk 3-10 fold via respiratory depression
20
African American race increases OSA risk 2-fold after BMI adjustment
21
Enlarged tonsils/adenoids cause 75% of pediatric OSA cases
22
High altitude (>2500m) increases CSA prevalence to 40% in newcomers
23
Asthma comorbidity raises OSA risk by 1.6 times
24
Atrial fibrillation patients have 4-fold higher OSA prevalence
25
Cystic fibrosis increases OSA risk via nasal obstruction
26
Erectile dysfunction in men with OSA has odds ratio of 2.1
27
Premature infants have 10-fold higher OSA risk in childhood
28
Shift work disrupts sleep architecture, increasing OSA risk by 50%
29
Chronic rhinosinusitis elevates OSA risk by 2.5 times
30
Bariatric surgery reduces OSA risk factors like BMI by 30-50kg loss
Interpretation
Risk Factors Interpretation
For the Risk Factors category, obesity stands out as the biggest driver, multiplying obstructive sleep apnea risk by 10-fold in men and 6-fold in women, while other contributors like smoking at 2.3 times and nasal congestion or allergies at 2.4 times further add to the overall risk.
More related reading
04 · Category
Symptoms/diagnosis30 stats
01
Loud snoring occurs in 70-90% of OSA patients nightly
02
Excessive daytime sleepiness affects 40-60% of untreated OSA patients, measured by Epworth Sleepiness Scale >10
03
Witnessed apneas reported by bed partners in 50% of moderate-severe OSA cases
04
Morning headaches occur in 15-25% of OSA patients due to hypercapnia
05
Nocturnal choking/gasping episodes in 30-50% of patients
06
Polysomnography (PSG) diagnoses OSA with AHI ≥5 events/hour in 85% accuracy
07
Epworth Sleepiness Scale (ESS) scores average 12.5 in OSA vs 5.2 in controls
08
Berlin Questionnaire has 0.86 sensitivity for moderate-severe OSA detection
09
Home sleep apnea testing (HSAT) correlates 90% with PSG for AHI ≥15
10
STOP-BANG score ≥3 predicts OSA with 86% sensitivity
11
Dry mouth upon waking reported by 40% of OSA sufferers
12
Nocturia (≥2 voids/night) in 50% of OSA patients vs 20% controls
13
Cognitive impairment like poor concentration in 35% of moderate OSA
14
Pulse oximetry desaturation <90% occurs in 70% of severe OSA nights
15
Multiple Sleep Latency Test (MSLT) shows mean sleep latency <8 min in 60% hypersomnolent OSA
16
Fatigue severity scale scores 4.5 in OSA vs 2.8 in non-OSA
17
Insomnia symptoms coexist in 40-55% of OSA patients
18
Pharyngeal examination shows Mallampati score IV in 60% OSA cases
19
AHI from PSG averages 35.2 events/hour in severe OSA (≥30)
20
O2 desaturation index (ODI) >20 correlates with AHI >15 in 92% cases
21
Pittsburgh Sleep Quality Index >5 in 70% untreated OSA
22
Partner-reported snoring intensity >50 dB in 80% OSA nights
23
Beck Depression Inventory scores 12.4 in OSA vs 5.6 controls
24
RVSP >30 mmHg on echo in 25% moderate OSA
25
Apnea duration averages 25-35 seconds in moderate OSA events
26
arousals index >20/hour in 65% severe OSA patients
27
ESS >15 indicates high sleepiness in 30% severe OSA
28
Noisy breathing during sleep noted in 85% pediatric OSA
29
Fatigue visual analog scale 65mm in OSA vs 25mm controls
30
Central apneas comprise 10-20% of events in mixed OSA/CSA
Interpretation
Symptoms/diagnosis Interpretation
In the Symptoms/diagnosis category, loud snoring shows up in 70 to 90% of OSA patients nightly, and along with daytime sleepiness in 40 to 60% and witnessed apneas in about 50% of moderate to severe cases, this pattern of recognition is typically confirmed by polysomnography with an AHI of at least 5 events per hour in roughly 85% of cases.
05 · Category
Treatment/management29 stats
01
CPAP reduces cardiovascular events by 36% in adherent patients
02
Oral appliances reduce AHI by 50% in mild-moderate OSA
03
Weight loss of 10% body weight decreases AHI by 26%
04
UPPP surgery success rate 40-60% for AHI reduction >50%
05
CPAP adherence averages 5.2 hours/night in first year
06
Positional therapy reduces supine AHI by 55% in positional OSA
07
ASV therapy lowers CSA events by 80% in heart failure patients
08
Mandibular advancement devices improve ESS by 4.2 points
09
Bariatric surgery resolves OSA in 75% super-obese patients
10
Hypoglossal nerve stimulation reduces AHI by 68% at 12 months
11
Tonsillectomy cures 75-100% pediatric OSA with tonsillar hypertrophy
12
CPAP lowers blood pressure by 2-4 mmHg systolic in hypertensives
13
Nasal EPAP devices reduce AHI by 40% in mild OSA
14
Exercise training alone reduces AHI by 17% independent of weight loss
15
Maxillomandibular advancement surgery achieves 85% cure rate
16
CPAP improves EF by 5-10% in heart failure with CSA
17
Smoking cessation reduces OSA severity by 10-20% over time
18
Cognitive behavioral therapy improves CPAP adherence by 50%
19
Tracheostomy resolves OSA in 95% severe cases refractory to CPAP
20
Weight management programs achieve 15% weight loss, halving AHI
21
Oxygen supplementation reduces ODI by 30% in CSA
22
Radiofrequency ablation reduces AHI by 20-40% in tongue base
23
CPAP decreases stroke risk by 40% with >4 hours use
24
Adenotonsillectomy improves quality of life scores by 2 SD in kids
25
Telemonitoring boosts CPAP adherence to 6.5 hours/night
26
Myofunctional therapy reduces AHI by 50% in children
27
Bilevel PAP preferred in 20% CPAP-intolerant, reduces AHI 70%
28
Didgeridoo playing strengthens airway, reduces daytime sleepiness by 25%
29
Pillar implants reduce snoring by 50% and AHI by 20%
Interpretation
Treatment/management Interpretation
For treatment and management of sleep apnea, the most notable trend is that targeted interventions can deliver large respiratory and risk improvements, with weight loss of 10% cutting AHI by 26%, oral appliances halving AHI in mild to moderate cases, and CPAP in adherent patients reducing cardiovascular events by 36%.
report visual · Breakdown
High prevalence and underdiagnosis of OSA
OSA is common in adults—and a large share of cases remain undiagnosed.
50%
Untreated OSA increases hypertension risk by 50%
50%
In elderly US populations (>65 years), OSA prevalence exceeds 50%
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Marcus Engström. (2026, February 13). Sleep Apnea Statistics. Gitnux. https://gitnux.org/sleep-apnea-statistics
MLA
Marcus Engström. "Sleep Apnea Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/sleep-apnea-statistics.
Chicago
Marcus Engström. 2026. "Sleep Apnea Statistics." Gitnux. https://gitnux.org/sleep-apnea-statistics.
Sources & references
32 datasets cited across this report · attribution is report-level